Psychiatr. pro Praxi, 2010; 11(1): 15-17

The combination of antipsychotics in the treatment of schizophrenia

doc.MUDr.Radovan Přikryl, Ph.D., PhDr.Hana Přikrylová-Kučerová, Ph.D.
Psychiatrická klinika LF MU a FN Brno

Use of combined antipsychotics for patients with treatment resistant schizophrenia is common practice in psychiatry. For patients who

have not responded to non-clozapine monotherapy, and are unable to use or unresponsive to clozapine, combination therapy with other

antipsychotics is another alternative.

Keywords: antipsychotics, combination, schizophrenia

Published: January 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Přikryl R, Přikrylová-Kučerová H. The combination of antipsychotics in the treatment of schizophrenia. Psychiatr. praxi. 2010;11(1):15-17.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 1988; 45: 789-796. Go to original source... Go to PubMed...
    2. Turkington D, Kingdon D, Weiden PJ. Cognitive behavior therapy for schizophrenia. Am J Psychiatry 2006; 163: 365-373. Go to original source... Go to PubMed...
    3. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 2003; 60: 553-564. Go to original source... Go to PubMed...
    4. Švestka, J. Clozapin. Prototyp antipsychotik nové generace. Maxdorf Jesenius, 1998: 89-105.
    5. Tiihonen J, Lonqvist J, Wahlbeck K, et al. 11-year followup of mortality in patients with schizophrenia: a population-based cohort study (FIN11-study). Lancet, published online July 13, 2009.
    6. Freudenreich O, Goff DC. Antipsychotic combination therapy in schizophrenia: a review of efficacy and risks of current combinations. Acta Psychiatr Scand 2002; 106: 323-330. Go to original source... Go to PubMed...
    7. Dunkley MJ, Reveley MA. Successful treatment of refractory schizophrenia with combined olanzapine and quetiapine in a patient with a prolactin secreting pituitary microademona. J Psychopharmacology 2005; 19: 97-101. Go to original source... Go to PubMed...
    8. Duggal SH. Aripiprazole-olanzapine combination for the treatment of schizophrenia. Canadian J Psych 2004; 49: 151. Go to original source... Go to PubMed...
    9. Lerner V, Bergman J, Borokhov A, et al. Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy. Clin Neuropharmacol. 2005; 28: 66-71. Go to original source... Go to PubMed...
    10. Zink M, Henn FA, Thome J. Combination of amisulpride and olanzapine in treatment-resistant schizophrenia psychoses. Eur Psychiatry 2004; 19: 56-58. Go to original source... Go to PubMed...
    11. Lerner V, Chudakova B, Kravets S, Polyakova I. Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report. Clin Neuropharmacol. 2000; 23: 284-286. Go to original source... Go to PubMed...
    12. John V, Rapp M, Pies R. Aggression, agitation, and mania with olanzapine (Letter). Can J Psychiatry 1998; 43: 1054.
    13. Seger A, Lamberti JS. Priapism associated with polypharmacy (Letter). J Clin Psychiatry 2001; 62: 128. Go to original source... Go to PubMed...
    14. Nelson MW, Reynolds RR, Kelly DL, Conley RR. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clin Neuropharmacol. 2003; 26: 297-298. Go to original source... Go to PubMed...
    15. Bozikas VP, Deseri C, Pitsavas S, Karavatos A. Anti-aggressive action of combined risperidone and quetiapine in a patient with schizophrenia (Letter). Can J Psychiatry 2003; 48: 426-427. Go to original source... Go to PubMed...
    16. Chue P, Welch R, Snaterse M. Combination risperidone and quetiapine therapy in refractory schizophrenia (Letter). Can J Psychiatry 2001; 46: 86-87.
    17. Jones GH., ,Clozapine effect" without the blood tests. Progress in neurology and psychiatry 2002; 6: 32.
    18. O'Shea M, Sazhin V, Collins A. Ventricular ectopics during crossover of atypical antipsychotics. Aus New Zealand J Psychiatry 2003; 37: 773-774. Go to original source... Go to PubMed...
    19. Hedges DW, Jeppson KG. New-onset seizure associated with quetiapine and olanzapine. Ann Pharmacother. 2002; 36: 437-439. Go to original source... Go to PubMed...
    20. DeQuardo JR. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? (Letter). J Clin Psychiatry 2004; 65: 132-133. Go to original source... Go to PubMed...
    21. Ramaswamy S, Vijay D, William M, et al. Aripiprazole possibly worsens psychosis. Int Clin Psychopharmacol. 2004; 19: 45-48. Go to original source... Go to PubMed...
    22. Reeves RR, Mack JE. Worsening schizoaffective disorder with aripiprazole (Letter). Am J Psychiatry 2004; 16: 1308. Go to original source... Go to PubMed...
    23. Paton C, Whittington, Barnes TR. Augmentation with a second antipsychotic in patient with schizophrenia who partially respond to clozapine. J Clin Psychopharmacol 2007; 27: 198-204. Go to original source... Go to PubMed...
    24. Taylor DM, Smith L. Augmentation of clozapine with a second antipsychotic - a meta-analysis of randomized, placebocontrolled studies, Acta Psychiatr Scand 2009; 119: 419-425. Go to original source... Go to PubMed...
    25. Braga RJ, Petrides G. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J ECT 2005; 21: 75-83. Go to original source... Go to PubMed...
    26. Češková E, Kašpárek T, Ondrušová M. Kombinace antipsychotik. Česká a slovenská psychiatrie 2001; 6: 286-290.
    27. Basan A, Kissling W, Leucht S. Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials. Schizophr Res. 2004; 70: 33-37. Go to original source... Go to PubMed...
    28. Citrome L, Casey DE, Daniel DG, et al. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. Psychiatr Serv. 2004; 55: 290-294. Go to original source... Go to PubMed...
    29. Kremer I, Vass A, Gorelik I, et al. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia. Biol Psychiatry 2004; 56: 441-446. Go to original source... Go to PubMed...
    30. Thomas R, Howe V, Foister K, Keks N. Adjunctive lamotrigine in treatment-resistant schizophrenia. Int J Neuropsychopharmacol. 2006; 9: 125-127. Go to original source... Go to PubMed...
    31. Skotáková S, Ustohal L, Přikryl R, Navrátilová P. Léčba sluchových halucinací pomocí repetitivní transkraniální magnetické stimulace (rTMS) aplikované na oblast temporoparietálního kortexu: kazuistické sdělení. Psychiatrie 2007; 11: 33.
    32. Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev. 2004; 4: CD000524. Go to original source... Go to PubMed...
    33. Češková E, Šulcová A. Antipsychotika na počátku třetího tisíciletí. Trendy ve farmakoterapii 2003; 39: 23-31.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.